Уважаемые пользователи!

Данный сайт содержит информацию для людей с медицинским образованием и специалистов здравоохранения.
Входя на сайт, Вы подтверждаете свое согласие с Условиями использования и Политикой конфиденциальности.

Dear visitor!
This site contains medical information for healthcare professionals.
You can go further, if you agree with Terms and Conditions and Privacy Policy on this site.

Dinamika faktorov riska sakharnogo diabeta 2 tipa i serdechno-sosudistykh zabolevaniy u bol'nykh s abdominal'nym tipom ozhireniya


  1. Бутрова С. А. Метаболический синдром: патогенез, клиника, диагностика, подходы к лечению. РМЖ. - 2001.- № 2 (9). - c. 56-60.
  2. Дедов И.И., Сунцов Ю.И., Кудрякова С.В. Эпидемиология сахарного диабета. Сахарный диабет. Руководство для врачей. Авт. Дедов И.И., Шестакова М.В. - М. - Универсум паблишинг 2003; 75-93.
  3. Науменкова И.В. Клинико-диагностические аспекты инсулинорезистентности у больных сахарным диабетом 2 типа на инсулинотерапии. Автореферат дис. канд. мед. наук. - М. 2002
  4. Boello O, Zamboni M. Visceral obesity and metabolic syndrome. Obes Rev 2000; 1: 47-56.
  5. Clinician's Manual on Total Risk Management. A guide to prevention of Coronary Heart Disease. Science Press Ltd and Society of Cardiology 2000.
  6. Mattews D, Hosker J, Rudenski A et al. Homeostasis model assessment: insulin resistance and ®-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
  7. Filipovsky J, Ducimeti_re P, Bernadette D, Richard LJ. Abdominal body mass distri- bution and elevated blood pressure are associated with increased risk of death from cardiovascular diseases and cancer in middle-aged men. The results of a 15-to 20- year follow-up in the Paris prospective study I. Int J Obes Relat Metab Disord 1993; 17: 197-203.
  8. Friedwald W, Levy R, Fredricson D. Estimation of the concentration of low-density- lipoprotein cholesterol in plasma, without use of the preparative ultra-centrifuge. Clinical Chem 1972; 18: 499-502.
  9. Gillum R, Mussolino M, Madans J. Body fat distribution, obesity, overweight and stroke incidence in women and men: the NHANES I Epidemic Follow-up Study. Int J Obes Relat Metab Disord 2001; 25: 628-638.
  10. Hube F, Hauner H. The role of TNF alpha in adipocyte tissue: prevention of weight gain at the expense of insulin resistance? Horm Metab Res 1999; 31: 626-631
  11. Li L, Lonnqvist F, Luthman H, Arner P. Phenotypic characterisation of the Trp64Arg polymorphism in the beta 3-adreergic receptor gene in normal weight and obese subjects. Diabetologia 1996; 39: 857-860
  12. Paolisso G, Taglanonte M, De Lucia D et al. ACE gene polymorphism and in-sulin action in older and healthy centenarians. J Am Geriartr Soc 2001; 49 (5): Abstract: 610-614
  13. Panahloo A, Andres G, Mohamed-Ali V et al. The insertion allele of the ACE gene I/D polymorphism a candidate gene for insulin resistance? Circulation 1995; 15; 92 (12): Abstract, 3390-3393.
  14. Pedersen O. Genetics of insulin resistance. Exp Clin Endocrinol Diab 1999; 107: 113..-1..1.8. .
  15. Pyorala K, Sovalainen E, Kaukola S, Haapakoski J. Plasma insulin as coronary heart disease risk factor: Relationship to other risk factors and predictive during 9 1/2 year follow-up of the Helsinki Policeman Study population. Acta Med Scan 1985; 701 (Suppl): 38-52.
  16. Tai E, Corella D, Wilson L et al. Association between the PPARA L162V polymorphism and plasma lipid levels. Interactions with the apoE, apoC3 and LPL LOCI: the Framingham Offspring Study. Atherosclerosis 2001;Vol 2: 33.
  17. Third Report of the National Cholesterol Education Progam (NCEP) Expert Panel on Detection, Evaluation and treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). NIH Publication 2001; 5. N 01-3670.
  18. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a Who consultation on obesity. World Health Organization: Geneva 1997; 218-219.


Abstract - 468

PDF (Russian) - 319

Copyright (c) 2004 Dedov I.I., Butrova S.A., Dzgoeva F.K.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.